PATENT CLAIM ANALYSIS

Application Number: 16228324
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-07
Patent Classification: ["514", "255050"]

Abstract:
The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.

Claim (Index 6):
The compound of  claim 1 , or a pharmaceutically acceptable salt, solvate, hydrate, tautomer, or isomer thereof, wherein Y 1  is \u2014NH\u2014, Y 1  is \u2014S(O) 2 \u2014, \u2014S(O) 2 NH\u2014 or \u2014C(\u2550CH) 2 \u2014.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16186490', '13352864', '14344628', '14670422', '14670421']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7869415410543495
- 35 USC 102 Novelty (BERT): 0.5405834043303417
- Combined Prediction Score: 0.7623057273819488
- Mean Citation Score: 355.792522
- Max Citation Score: 365.5356
- Similarity Product: 265.86094426760667

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test